CA
NZ
UK
AU
IND
US
Charles M. Lyon, President of StoneX Group Inc., filed a Form 4 on September 11, 2026, reporting a disposition of 500 shares of common stock on September 10, 2026, via a gift transaction at a price of $0.
A Form 4 filed on September 11, 2026 reports that Jin Lei, president of Youdao, Inc. (NYSE:DAO), sold 70,047 Class A Ordinary Shares on September 9, 2026, following the vesting and settlement of restricted stock units into American Depositary Shares.
A Form 4 filed on September 11, 2026 with the U.S. Securities and Exchange Commission reports that Peng Su, Senior Vice President of Youdao, Inc. (NYSE:DAO), sold 6,750 Class A Ordinary Shares on September 9, 2026 following a vesting and settlement of restricted stock …
Wu Yinghui, Senior Vice President of Youdao, Inc. (NYSE:DAO), filed a Form 4 on September 11, 2026, disclosing the vesting of 6,750 restricted stock units and a same-day sale of the resulting Class A Ordinary Shares on September 9, 2026.
Vera de Gyarfas, General Counsel of NextDecade Corp, filed a statement of changes in beneficial ownership with the SEC on September 11, 2026, reporting a transaction in the company's common stock dated September 9, 2026.
Matthew K. Schatzman, Chief Executive Officer and Director of NextDecade Corp, filed a Form 4 on September 11, 2026, disclosing a transaction dated September 9, 2026, involving the withholding of common stock shares to cover tax obligations related to vesting restricted stock units.
Corebridge Financial, Inc. filed a Statement of Changes in Beneficial Ownership with the SEC on September 11, 2026, disclosing the redemption of Series D Mandatory Redeemable Preferred Shares in Carlyle Tactical Private Credit Fund (TAKNX) on September 9, 2026.
A Form 4 filed on September 11, 2026 discloses that Tarik Skeik, Chief Operating Officer of NextDecade Corp (NASDAQ:NEXT), had 7,732 shares of common stock withheld by the company on September 9, 2026 to satisfy tax obligations connected to the vesting of restricted stock …
Sergio Traversa, Chief Executive Officer and Director of Relmada Therapeutics, Inc. (NASDAQ:RLMD), filed a Form 4 on September 11, 2026, disclosing two open market purchases of common stock totaling 200,000 shares on September 9 and September 10, 2026.
Maged Shenouda, Chief Financial Officer of Relmada Therapeutics, Inc. (NASDAQ:RLMD), filed a Form 4 on September 11, 2026, disclosing open market purchases of 200,000 shares of common stock across two trading days, September 9 and September 10, 2026.
Please wait processing your request...